{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T18:35:07Z","timestamp":1794335707366,"version":"4.9.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["1U54NS115198-01"],"award-info":[{"award-number":["1U54NS115198-01"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["18-007276"],"award-info":[{"award-number":["18-007276"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["19-005187"],"award-info":[{"award-number":["19-005187"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016650","name":"Rare Diseases Clinical Research Network","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016650","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["gimjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genetics in Medicine"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.gim.2023.101027","type":"journal-article","created":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T13:55:20Z","timestamp":1699624520000},"page":"101027","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Neurological manifestations in PMM2-congenital disorders of glycosylation (PMM2-CDG): Insights into clinico-radiological characteristics, recommendations for follow-up, and future directions"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1009-6555","authenticated-orcid":false,"given":"Karthik","family":"Muthusamy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judit M.","family":"Perez-Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna N.","family":"Ligezka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruqaiah","family":"Altassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christin","family":"Johnsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Schultz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc C.","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Morava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.gim.2023.101027_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagen.2021.129976","article-title":"The evolving genetic landscape of congenital disorders of glycosylation","volume":"1865","author":"Wilson","year":"2021","journal-title":"Biochim Biophys Acta Gen Subj"},{"issue":"6","key":"10.1016\/j.gim.2023.101027_bib2","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.molmed.2022.04.003","article-title":"Nutrition interventions in congenital disorders of glycosylation","volume":"28","author":"Boyer","year":"2022","journal-title":"Trends Mol Med"},{"issue":"11","key":"10.1016\/j.gim.2023.101027_bib3","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.ejmg.2017.10.012","article-title":"Congenital disorders of glycosylation (CDG): quo vadis?","volume":"61","author":"P\u00e9anne","year":"2018","journal-title":"Eur J Med Genet"},{"issue":"5","key":"10.1016\/j.gim.2023.101027_bib4","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S1474-4422(12)70040-6","article-title":"Neurology of inherited glycosylation disorders","volume":"11","author":"Freeze","year":"2012","journal-title":"Lancet Neurol"},{"issue":"4","key":"10.1016\/j.gim.2023.101027_bib5","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.celrep.2019.03.107","article-title":"Modeling glycan processing reveals Golgi-enzyme homeostasis upon trafficking defects and cellular differentiation","volume":"27","author":"Fisher","year":"2019","journal-title":"Cell Rep"},{"issue":"2","key":"10.1016\/j.gim.2023.101027_bib6","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41436-019-0647-2","article-title":"Therapeutic approaches in Congenital Disorders of Glycosylation (CDG) involving N-linked glycosylation: an update","volume":"22","author":"Verheijen","year":"2020","journal-title":"Genet Med"},{"issue":"2","key":"10.1016\/j.gim.2023.101027_bib7","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1006\/mgme.1999.2914","article-title":"Phosphomannomutase deficiency: the molecular basis of the classical Jaeken syndrome (CDGS type Ia)","volume":"68","author":"Matthijs","year":"1999","journal-title":"Mol Genet Metab"},{"issue":"1","key":"10.1016\/j.gim.2023.101027_bib8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/jimd.12024","article-title":"International clinical guidelines for the management of phosphomannomutase 2-congenital disorders of glycosylation: diagnosis, treatment and follow up","volume":"42","author":"Altassan","year":"2019","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1016\/j.gim.2023.101027_bib9","unstructured":"Lam C, Krasnewich DM. PMM2-CDG. August 15, 2005; updated May 20, 2021. In: Adam MP, Mirzaa GM, Pagon RA, et\u00a0al., eds. GeneReviews\u00ae [internet]. 1993-2023. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1110\/"},{"issue":"5","key":"10.1016\/j.gim.2023.101027_bib10","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/ana.25457","article-title":"AZATAX: acetazolamide safety and efficacy in cerebellar syndrome in PMM2 congenital disorder of glycosylation (PMM2-CDG)","volume":"85","author":"Mart\u00ednez-Monseny","year":"2019","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1016\/j.gim.2023.101027_bib11","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","article-title":"Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies","volume":"51","author":"Kwan","year":"2010","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.gim.2023.101027_bib12","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ymgme.2022.04.002","article-title":"Patient-reported outcomes and quality of life in PMM2-CDG","volume":"136","author":"Ligezka","year":"2022","journal-title":"Mol Genet Metab"},{"issue":"4","key":"10.1016\/j.gim.2023.101027_bib13","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s10545-011-9325-5","article-title":"Nijmegen paediatric CDG rating scale: a novel tool to assess disease progression","volume":"34","author":"Achouitar","year":"2011","journal-title":"J\u00a0Inherit Metab Dis"},{"issue":"11","key":"10.1016\/j.gim.2023.101027_bib14","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.3390\/genes12111658","article-title":"Genotype-phenotype correlations in PMM2-CDG","volume":"12","author":"Vaes","year":"2021","journal-title":"Genes (Basel)"},{"issue":"3","key":"10.1016\/j.gim.2023.101027_bib15","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/clinchem\/47.3.513","article-title":"Rapid determination of transferrin isoforms by immunoaffinity liquid chromatography and electrospray mass spectrometry","volume":"47","author":"Lacey","year":"2001","journal-title":"Clin Chem"},{"issue":"6","key":"10.1016\/j.gim.2023.101027_bib16","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1177\/088307380101600604","article-title":"Neurologic course of congenital disorders of glycosylation","volume":"16","author":"Pearl","year":"2001","journal-title":"J\u00a0Child Neurol"},{"key":"10.1016\/j.gim.2023.101027_bib17","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s13023-015-0358-y","article-title":"Phosphomannomutase deficiency (PMM2-CDG): ataxia and cerebellar assessment","volume":"10","author":"Serrano","year":"2015","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"10.1016\/j.gim.2023.101027_bib18","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1007\/s12311-021-01242-x","article-title":"Clinical and radiological correlates of activities of daily living in cerebellar atrophy caused by PMM2 mutations (PMM2-CDG)","volume":"20","author":"Pettinato","year":"2021","journal-title":"Cerebellum"},{"issue":"1","key":"10.1016\/j.gim.2023.101027_bib19","first-page":"154","article-title":"A\u00a0nationwide survey of PMM2-CDG in Italy: high frequency of a mild neurological variant associated with the L32R mutation","volume":"262","author":"Barone","year":"2015","journal-title":"J\u00a0Neurol"},{"issue":"5","key":"10.1016\/j.gim.2023.101027_bib20","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s10545-017-0073-z","article-title":"PMM2-CDG and sensorineural hearing loss","volume":"40","author":"Kasapkara","year":"2017","journal-title":"J\u00a0Inherit Metab Dis"},{"issue":"3","key":"10.1016\/j.gim.2023.101027_bib21","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1136\/adc.85.3.236","article-title":"Congenital disorder of glycosylation type Ia (CDG-Ia): phenotypic spectrum of the R141H\/F119L genotype","volume":"85","author":"Kjaergaard","year":"2001","journal-title":"Arch Dis Child"},{"issue":"3","key":"10.1016\/j.gim.2023.101027_bib22","doi-asserted-by":"crossref","first-page":"e768","DOI":"10.1542\/peds.2006-0763","article-title":"Radiologic and neurophysiologic aspects of stroke-like episodes in children with congenital disorder of glycosylation type Ia","volume":"119","author":"Dinopoulos","year":"2007","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.gim.2023.101027_bib23","doi-asserted-by":"crossref","first-page":"619","DOI":"10.3390\/ijms19020619","article-title":"Stroke-like episodes and cerebellar syndrome in phosphomannomutase deficiency\u00a0(PMM2-CDG): evidence for hypoglycosylation-driven channelopathy","volume":"19","author":"Izquierdo-Serra","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.gim.2023.101027_bib24","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/s42003-021-02528-w","article-title":"Modified N-linked glycosylation status predicts trafficking defective human Piezo1 channel mutations","volume":"4","author":"Li","year":"2021","journal-title":"Commun Biol"},{"issue":"2","key":"10.1016\/j.gim.2023.101027_bib25","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.braindev.2008.08.014","article-title":"Increased brain lactate during stroke-like episode in a patient with congenital disorder of glycosylation type Ia","volume":"31","author":"van Baalen","year":"2009","journal-title":"Brain Dev"},{"issue":"12","key":"10.1016\/j.gim.2023.101027_bib26","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1136\/jmedgenet-2017-104903","article-title":"Clinical, laboratory and molecular findings and long-term follow-up data in 96 French patients with PMM2-CDG (phosphomannomutase 2-congenital disorder of glycosylation) and review of the literature","volume":"54","author":"Schiff","year":"2017","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.gim.2023.101027_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.717864","article-title":"Stroke-like episodes in PMM2-CDG: when the lack of other evidence is the only evidence","volume":"9","author":"Serrano","year":"2021","journal-title":"Front Pediatr"},{"issue":"5","key":"10.1016\/j.gim.2023.101027_bib28","doi-asserted-by":"crossref","first-page":"546","DOI":"10.3171\/2014.7.PEDS14102","article-title":"Initial diagnosis of the congenital disorder of glycosylation PMM2-CDG (CDG1a) in a 4-year-old girl after neurosurgical intervention for cerebral hemorrhage","volume":"14","author":"Stefanits","year":"2014","journal-title":"J\u00a0Neurosurg Pediatr"},{"issue":"11","key":"10.1016\/j.gim.2023.101027_bib29","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.3174\/ajnr.A3151","article-title":"The shrunken, bright cerebellum: a characteristic MRI finding in congenital disorders of glycosylation type 1a","volume":"33","author":"Feraco","year":"2012","journal-title":"AJNR Am J Neuroradiol"},{"issue":"18","key":"10.1016\/j.gim.2023.101027_bib30","doi-asserted-by":"crossref","first-page":"8522","DOI":"10.3390\/app11188522","article-title":"Neuroimaging of pediatric cerebellum in inherited neurodegenerative diseases","volume":"11","author":"Chiapparini","year":"2021","journal-title":"Appl Sci Basel"},{"key":"10.1016\/j.gim.2023.101027_bib31","first-page":"107","article-title":"Further delineation of the phenotype of congenital disorder of glycosylation DPAGT1-CDG (CDG-Ij) identified by homozygosity mapping","volume":"2","author":"Imtiaz","year":"2012","journal-title":"JIMD Rep"},{"issue":"7","key":"10.1016\/j.gim.2023.101027_bib32","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1212\/WNL.0000000000004234","article-title":"Early and lethal neurodegeneration with myasthenic and myopathic features: a new ALG14-CDG","volume":"89","author":"Schorling","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.gim.2023.101027_bib33","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s13023-014-0207-4","article-title":"29 French adult patients with PMM2-congenital disorder of glycosylation: outcome of the classical pediatric phenotype and depiction of a late-onset phenotype","volume":"9","author":"Monin","year":"2014","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"10.1016\/j.gim.2023.101027_bib34","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s13023-017-0707-0","article-title":"A\u00a0quantitative assessment of the evolution of cerebellar syndrome in children with phosphomannomutase-deficiency (PMM2-CDG)","volume":"12","author":"Serrano","year":"2017","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"10.1016\/j.gim.2023.101027_bib35","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s10545-017-0028-4","article-title":"Longitudinal volumetric and 2D assessment of cerebellar atrophy in a large cohort of children with phosphomannomutase deficiency (PMM2-CDG)","volume":"40","author":"de Diego","year":"2017","journal-title":"J\u00a0Inherit Metab Dis"},{"issue":"4","key":"10.1016\/j.gim.2023.101027_bib36","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00431-006-0240-y","article-title":"Early fatal course in siblings with CDG-Ia (caused by two novel mutations in the PMM2 gene): clinical, molecular and autopsy findings","volume":"166","author":"Wurm","year":"2007","journal-title":"Eur J Pediatr"},{"issue":"1","key":"10.1016\/j.gim.2023.101027_bib37","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s13023-021-01751-2","article-title":"Spontaneous improvement of carbohydrate-deficient transferrin in PMM2-CDG without mannose observed in CDG natural history study","volume":"16","author":"Witters","year":"2021","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"10.1016\/j.gim.2023.101027_bib38","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/s41436-018-0301-4","article-title":"Long-term follow-up in PMM2-CDG: are we ready to start treatment trials?","volume":"21","author":"Witters","year":"2019","journal-title":"Genet Med"},{"issue":"11","key":"10.1016\/j.gim.2023.101027_bib39","article-title":"Repurposing the aldose reductase inhibitor and diabetic neuropathy drug epalrestat for the congenital disorder of glycosylation PMM2-CDG","volume":"12","author":"Iyer","year":"2019","journal-title":"Dis Model Mech"},{"issue":"6","key":"10.1016\/j.gim.2023.101027_bib40","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/ana.26245","article-title":"Sorbitol is a severity biomarker for PMM2-CDG with therapeutic implications","volume":"90","author":"Ligezka","year":"2021","journal-title":"Ann Neurol"},{"issue":"11","key":"10.1016\/j.gim.2023.101027_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagen.2020.129686","article-title":"New and potential strategies for the treatment of PMM2-CDG","volume":"1864","author":"G\u00e1mez","year":"2020","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"10.1016\/j.gim.2023.101027_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.735348","article-title":"Treatment options in congenital disorders of glycosylation","volume":"12","author":"Park","year":"2021","journal-title":"Front Genet"}],"container-title":["Genetics in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098360023010432?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098360023010432?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T01:56:38Z","timestamp":1761098198000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098360023010432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S1098360023010432"],"URL":"https:\/\/doi.org\/10.1016\/j.gim.2023.101027","relation":{},"ISSN":["1098-3600"],"issn-type":[{"value":"1098-3600","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurological manifestations in PMM2-congenital disorders of glycosylation (PMM2-CDG): Insights into clinico-radiological characteristics, recommendations for follow-up, and future directions","name":"articletitle","label":"Article Title"},{"value":"Genetics in Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gim.2023.101027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American College of Medical Genetics and Genomics. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101027"}}